Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.
作者信息
Chakrabarti P, Wong H Y, Toyofuku A, Scantlebury V P, Jordan M L, Vivas C, Jain A B, McCauley J, Johnston J, Randhawa P S, Hakala T R, Simmons R L, Fung J J, Starzl T E, Shapiro R
机构信息
Thomas E. Starzl Transplantation Institute, University of Pittsburgh, 15213, Pittsburgh, PA, USA.
出版信息
Transplant Proc. 2001 Feb-Mar;33(1-2):1235-6. doi: 10.1016/s0041-1345(00)02402-7.
Abstract
摘要
相似文献
1
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.接受以他克莫司为基础的免疫抑制治疗的成年肾移植患者停用类固醇后的结果。
Transplant Proc. 2001 Feb-Mar;33(1-2):1235-6. doi: 10.1016/s0041-1345(00)02402-7.
2
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.接受以他克莫司为基础的免疫抑制治疗的小儿肾移植患者停用类固醇后的结果。
Transplantation. 2000 Sep 15;70(5):760-4. doi: 10.1097/00007890-200009150-00008.
3
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.接受以他克莫司为基础的免疫抑制治疗的肾移植患者停用类固醇后的结局。
Transplant Proc. 1998 Jun;30(4):1375-7. doi: 10.1016/s0041-1345(98)00280-2.
4
Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens.肾移植受者中的类固醇撤减或类固醇避免：聚焦于以他克莫司为基础的免疫抑制方案。
Transplant Proc. 2005 May;37(4):1789-91. doi: 10.1016/j.transproceed.2005.03.139.
5
Early steroid withdrawal in solitary pancreas transplantation results in equivalent graft and patient survival compared with maintenance steroid therapy.与维持性类固醇治疗相比，孤立胰腺移植中早期停用类固醇可使移植物和患者生存率相当。
Clin Transplant. 2007 Jul-Aug;21(4):491-7. doi: 10.1111/j.1399-0012.2007.00675.x.
6
Tacrolimus-based immunosuppression in pediatric renal transplantation.小儿肾移植中基于他克莫司的免疫抑制治疗
Transplant Proc. 1999 Nov;31(7A):29S-30S. doi: 10.1016/s0041-1345(99)00790-3.
7
Pediatric renal transplantation under tacrolimus-based immunosuppression.基于他克莫司的免疫抑制下的小儿肾移植
Transplantation. 1999 Jan 27;67(2):299-303. doi: 10.1097/00007890-199901270-00020.
8
Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.他克莫司为基础、不含激素的肾移植方案：ATLAS 试验 3 年随访结果。
Transplantation. 2012 Sep 15;94(5):492-8. doi: 10.1097/TP.0b013e31825c1d6c.
9
A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring.三种肾移植诱导抗体的随机试验：他克莫司、霉酚酸酯和类固醇给药的早期比较以及新型免疫监测
Transplantation. 2005 Aug 27;80(4):457-65. doi: 10.1097/01.tp.0000165847.05787.08.
10
Long-term prednisolone withdrawal after pancreas and kidney transplantation in patients treated with ATG, tacrolimus, and mycophenolate mofetil.接受抗胸腺细胞球蛋白、他克莫司和霉酚酸酯治疗的患者在胰腺和肾脏移植后长期停用泼尼松龙。
Transplant Proc. 2001 Feb-Mar;33(1-2):1694-5. doi: 10.1016/s0041-1345(00)02645-2.
本文引用的文献
1
Corticosteroid withdrawal in renal transplantation.肾移植中糖皮质激素的撤减
Transplant Proc. 1999 Feb-Mar;31(1-2):247-8. doi: 10.1016/s0041-1345(98)01521-8.
2
Pediatric renal transplantation under tacrolimus-based immunosuppression.基于他克莫司的免疫抑制下的小儿肾移植
Transplantation. 1999 Jan 27;67(2):299-303. doi: 10.1097/00007890-199901270-00020.
3
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression.肾移植术后1周停用皮质类固醇，采用基于他克莫司/霉酚酸酯的免疫抑制方案。
Transplant Proc. 1998 Jun;30(4):1378-9. doi: 10.1016/s0041-1345(98)00281-4.
4
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.接受以他克莫司为基础的免疫抑制治疗的肾移植患者停用类固醇后的结局。
Transplant Proc. 1998 Jun;30(4):1375-7. doi: 10.1016/s0041-1345(98)00280-2.
5
Tacrolimus (FK-506) in kidney transplantation.肾移植中的他克莫司（FK-506）。
Transplant Proc. 1997 Feb-Mar;29(1-2):45-7. doi: 10.1016/s0041-1345(96)00007-3.
6
Tacrolimus in pediatric renal transplantation.他克莫司在小儿肾移植中的应用
Transplantation. 1996 Dec 27;62(12):1752-8. doi: 10.1097/00007890-199612270-00010.
7
Tacrolimus in renal transplantation.他克莫司在肾移植中的应用。
Transplant Proc. 1996 Aug;28(4):2117-8.
Zotero 插件